Cholinesterase inhibitors (ChEIs), which can recover the level of acetylcholine (activator of α7nAChR) in the central nervous system in AD brain, is one of the two types of medications for AD treatment approved by the Food and Drug Administration (Uddin et al., 2020). The gene discussed is BCHE; the disease is Alzheimer disease.